Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis.
Authors | |
Keywords | |
Abstract | BACKGROUND & AIMS: Red and processed meat intake is associated with colorectal cancer (CRC) incidence, but it is not clear if intake is associated with patient survival after diagnosis. METHODS: We pooled data from 7627 patients with stage I-IV CRC from 10 studies in the International Survival Analysis in Colorectal Cancer Consortium. Cox proportional hazards regression models were used to evaluate the associations of intake of red and processed meat before diagnosis with overall and CRC-specific survival. RESULTS: Among 7627 patients with CRC, 2338 died, including 1576 from CRC, over a median follow-up time of 5.1 years. In multivariable-adjusted analyses, higher intake of red or processed meat was not associated with overall survival of patients with stage I-III CRC: Q4 vs Q1 red meat hazard ratio [HR], 1.08 (95% CI, 0.93-1.26) and Q4 vs Q1 processed meat HR, 1.10 (95% CI, 0.93-1.32) or with CRC-specific survival: Q4 vs Q1 red meat HR, 1.09 (95% CI, 0.89-1.33) and Q4 vs Q1 processed meat HR, 1.11 (95% CI, 0.87-1.42). Results were similar for patients with stage IV CRC. However, patients with stage I-III CRC who reported an intake of processed meat above the study-specific medians had a higher risk of death from any cause (HR, 1.12; 95% CI, 1.01-1.25) than patients who reported eating at or less than the median. CONCLUSION: In this large consortium of CRC patient cohorts, intake of red and processed meat before a diagnosis of CRC was not associated with shorter survival time after diagnosis, although a possible weak adverse association cannot be excluded. Studies that evaluate dietary data from several time points before and after cancer diagnosis are required to confirm these findings. |
Year of Publication | 2019
|
Journal | Clin Gastroenterol Hepatol
|
Volume | 17
|
Issue | 8
|
Pages | 1561-1570.e3
|
Date Published | 2019 Jul
|
ISSN | 1542-7714
|
DOI | 10.1016/j.cgh.2018.11.036
|
PubMed ID | 30476588
|
PubMed Central ID | PMC6533164
|
Links | |
Grant list | R01 CA059045 / CA / NCI NIH HHS / United States
HHSN268201100001I / HL / NHLBI NIH HHS / United States
R35 CA197735 / CA / NCI NIH HHS / United States
P01 CA087969 / CA / NCI NIH HHS / United States
HHSN268201100004I / HL / NHLBI NIH HHS / United States
K05 CA154337 / CA / NCI NIH HHS / United States
P01 CA055075 / CA / NCI NIH HHS / United States
R01 CA151993 / CA / NCI NIH HHS / United States
HHSN268201100046C / HL / NHLBI NIH HHS / United States
P30 CA086862 / CA / NCI NIH HHS / United States
U01 CA167552 / CA / NCI NIH HHS / United States
R01 CA048998 / CA / NCI NIH HHS / United States
U01 CA137088 / CA / NCI NIH HHS / United States
HHSN268201100003C / WH / WHI NIH HHS / United States
U24 CA074794 / CA / NCI NIH HHS / United States
R01 CA137178 / CA / NCI NIH HHS / United States
U01 CA074794 / CA / NCI NIH HHS / United States
R01 CA176272 / CA / NCI NIH HHS / United States
U01 CA167551 / CA / NCI NIH HHS / United States
HHSN271201100004C / AG / NIA NIH HHS / United States
UM1 CA186107 / CA / NCI NIH HHS / United States
HHSN268201100002C / WH / WHI NIH HHS / United States
R01 CA042182 / CA / NCI NIH HHS / United States
UM1 CA167552 / CA / NCI NIH HHS / United States
K05 CA152715 / CA / NCI NIH HHS / United States
UM1 CA167551 / CA / NCI NIH HHS / United States
S10 OD020069 / OD / NIH HHS / United States
HHSN268201100002I / HL / NHLBI NIH HHS / United States
P50 CA127003 / CA / NCI NIH HHS / United States
HHSN268201100001C / WH / WHI NIH HHS / United States
HHSN268201100004C / WH / WHI NIH HHS / United States
|